Tumour Treating Fields in combination with pemetrexed and cisplatin or carboplatin as first-line treatment for unresectable malignant pleural mesothelioma (STELLAR): a multicentre,... by Ceresoli, Giovanni L, MD, Aerts, Joachim G, Prof, Dziadziuszko, Rafal, Prof, Ramlau, Rodryg, MD, Cedres, Susana, MD, van Meerbeeck, Jan P, Prof, Mencoboni, Manlio, MD, Planchard, David, MD, Chella, Antonio, MD, Crinò, Lucio, MD, Krzakowski, Maciej, MD, Rüssel, Jörn, MD, Maconi, Antonio, MD, Gianoncelli, Letizia, MD, Grosso, Federica, MD

Get full text

Tremelimumab as second-line or third-line treatment in relapsed malignant mesothelioma (DETERMINE): a multicentre, international, randomised, double-blind, placebo-controlled phase... by Maio, Michele, Prof, Scherpereel, Arnaud, Prof, Calabrò, Luana, MD, Aerts, Joachim, MD, Perez, Susana Cedres, PhMd, Bearz, Alessandra, MD, Nackaerts, Kristiaan, MD, Fennell, Dean A, Prof, Kowalski, Dariusz, MD, Tsao, Anne S, Prof, Taylor, Paul, MBChB, Grosso, Federica, MD, Antonia, Scott J, Prof, Nowak, Anna K, Prof, Taboada, Maria, MSc, Puglisi, Martina, MD, Stockman, Paul K, MBChB, Kindler, Hedy L, Prof

Get full text

Anetumab ravtansine versus vinorelbine in patients with relapsed, mesothelin-positive malignant pleural mesothelioma (ARCS-M): a randomised, open-label phase 2 trial by Kindler, Hedy L, Prof, Novello, Silvia, Prof, Bearz, Alessandra, MD, Ceresoli, Giovanni L, MD, Aerts, Joachim G J V, Prof, Spicer, James, Prof, Taylor, Paul, MB ChB, Nackaerts, Kristiaan, Prof, Greystoke, Alastair, MBChB, Jennens, Ross, MBBS, Calabrò, Luana, MD, Burgers, Jacobus A, MD, Santoro, Armando, Prof, Cedrés, Susana, MD, Serwatowski, Piotr, MD, Ponce, Santiago, MD, Van Meerbeeck, Jan P, Prof, Nowak, Anna K, Prof, Blumenschein, George, Prof, Siegel, Jonathan M, MS, Kasten, Linda, MA, Köchert, Karl, PhD, Walter, Annette O, PhD, Childs, Barrett H, MD, Elbi, Cem, MD, Hassan, Raffit, MD, Fennell, Dean A, Prof

Get full text

Single-Dose Relative Bioavailability of a New Quetiapine Fumarate Extended-Release Formulation: A Postprandial, Randomized, Open-Label, Two-Period Crossover Study in Healthy Urugua... by Estevez-Carrizo, Francisco E., MD, Parrillo, Susana, MD, Ercoli, Mónica Cedres, PharmD, Estevez-Parrillo, Francisco T., BM

Get full text

Bioequivalence of two film-coated tablets of imatinib mesylate 400 mg: A randomized, open-label, single-dose, fasting, two-period, two-sequence crossover comparison in healthy male... by Parrillo-Campiglia, Susana, MD, Ercoli, Mónica Cedres, PharmD, Umpierrez, Ofelia, MD, Rodríguez, Patricia, PharmD, Márquez, Sara, BM, Guarneri, Carolina, BM, Estevez-Parrillo, Francisco T., BM, Laurenz, Marilena, Lic. Enf, Estevez-Carrizo, Francisco E., MD

Get full text